Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,980 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
What We Know About Tuberculosis Transmission: An Overview.
Churchyard G, Kim P, Shah NS, Rustomjee R, Gandhi N, Mathema B, Dowdy D, Kasmar A, Cardenas V. Churchyard G, et al. Among authors: kim p. J Infect Dis. 2017 Nov 3;216(suppl_6):S629-S635. doi: 10.1093/infdis/jix362. J Infect Dis. 2017. PMID: 29112747 Free PMC article. Review.
Alignment of new tuberculosis drug regimens and drug susceptibility testing: a framework for action.
Wells WA, Boehme CC, Cobelens FG, Daniels C, Dowdy D, Gardiner E, Gheuens J, Kim P, Kimerling ME, Kreiswirth B, Lienhardt C, Mdluli K, Pai M, Perkins MD, Peter T, Zignol M, Zumla A, Schito M. Wells WA, et al. Among authors: kim p. Lancet Infect Dis. 2013 May;13(5):449-58. doi: 10.1016/S1473-3099(13)70025-2. Epub 2013 Mar 24. Lancet Infect Dis. 2013. PMID: 23531393 Free PMC article. Review.
Getting to Zero New Tuberculosis Infections: Insights From the National Institutes of Health/US Centers for Disease Control and Prevention/Bill & Melinda Gates Foundation Workshop on Research Needs for Halting Tuberculosis Transmission.
Shah NS, Kim P, Kana BD, Rustomjee R. Shah NS, et al. Among authors: kim p. J Infect Dis. 2017 Nov 3;216(suppl_6):S627-S628. doi: 10.1093/infdis/jix311. J Infect Dis. 2017. PMID: 29112742 Free PMC article. No abstract available.
Target regimen profiles for tuberculosis treatment.
Lienhardt C, Dooley KE, Nahid P, Wells C, Ryckman TS, Kendall EA, Davies G, Brigden G, Churchyard G, Cirillo DM, Di Meco E, Gopinath R, Mitnick C, Scott C, Amanullah F, Bansbach C, Boeree M, Campbell M, Conradie F, Crook A, Daley CL, Dheda K, Diacon A, Gebhard A, Hanna D, Heinrich N, Hesseling A, Holtzman D, Jachym M, Kim P, Lange C, McKenna L, Meintjes G, Ndjeka N, Nhung NV, Nyang'wa BT, Paton NI, Rao R, Rich M, Savic R, Schoeman I, Makokotlela BS, Spigelman M, Sun E, Svensson E, Tisile P, Varaine F, Vernon A, Diul MY, Kasaeva T, Zignol M, Gegia M, Mirzayev F, Schumacher SG. Lienhardt C, et al. Among authors: kim p. Bull World Health Organ. 2024 Aug 1;102(8):600-607. doi: 10.2471/BLT.24.291881. Epub 2024 May 28. Bull World Health Organ. 2024. PMID: 39070602 Free PMC article.
Viewpoint: Challenges and opportunities in tuberculosis research.
Kim PS, Makhene M, Sizemore C, Hafner R. Kim PS, et al. J Infect Dis. 2012 May 15;205 Suppl 2(Suppl 2):S347-52. doi: 10.1093/infdis/jis190. Epub 2012 Mar 22. J Infect Dis. 2012. PMID: 22448021 Free PMC article. No abstract available.
Clinical research and development of tuberculosis diagnostics: moving from silos to synergy.
Nahid P, Kim PS, Evans CA, Alland D, Barer M, Diefenbach J, Ellner J, Hafner R, Hamilton CD, Iademarco MF, Ireton G, Kimerling ME, Lienhardt C, MacKenzie WR, Murray M, Perkins MD, Posey JE, Roberts T, Sizemore C, Stevens WS, Via L, Williams SD, Yew WW, Swindells S. Nahid P, et al. Among authors: kim ps. J Infect Dis. 2012 May 15;205 Suppl 2(Suppl 2):S159-68. doi: 10.1093/infdis/jis194. Epub 2012 Apr 3. J Infect Dis. 2012. PMID: 22476718 Free PMC article. Review.
Drug-resistant tuberculosis: time for visionary political leadership.
Abubakar I, Zignol M, Falzon D, Raviglione M, Ditiu L, Masham S, Adetifa I, Ford N, Cox H, Lawn SD, Marais BJ, McHugh TD, Mwaba P, Bates M, Lipman M, Zijenah L, Logan S, McNerney R, Zumla A, Sarda K, Nahid P, Hoelscher M, Pletschette M, Memish ZA, Kim P, Hafner R, Cole S, Migliori GB, Maeurer M, Schito M, Zumla A. Abubakar I, et al. Among authors: kim p. Lancet Infect Dis. 2013 Jun;13(6):529-39. doi: 10.1016/S1473-3099(13)70030-6. Epub 2013 Mar 24. Lancet Infect Dis. 2013. PMID: 23531391 Free article. Review.
Efavirenz Pharmacokinetics and Pharmacodynamics in HIV-Infected Persons Receiving Rifapentine and Isoniazid for Tuberculosis Prevention.
Podany AT, Bao Y, Swindells S, Chaisson RE, Andersen JW, Mwelase T, Supparatpinyo K, Mohapi L, Gupta A, Benson CA, Kim P, Fletcher CV; AIDS Clinical Trials Group A5279 Study Team. Podany AT, et al. Among authors: kim p. Clin Infect Dis. 2015 Oct 15;61(8):1322-7. doi: 10.1093/cid/civ464. Epub 2015 Jun 16. Clin Infect Dis. 2015. PMID: 26082504 Free PMC article. Clinical Trial.
4,980 results